L&C Bio Co. Ltd (290650) — Cash Flow Quality Index
L&C Bio Co. Ltd (290650) has a Cash Flow Quality Index of -0.06x as of December 2024. Operating cash flow of ₩-8.57 Billion is below net income of ₩140.97 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 290650 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
L&C Bio Co. Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for L&C Bio Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check L&C Bio Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for L&C Bio Co. Ltd (2015–2024)
Year-by-year earnings quality comparison for L&C Bio Co. Ltd. For live market cap and the full company financial profile, see L&C Bio Co. Ltd market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | ₩-8.57 Billion | ₩140.97 Billion | ▲ +75.8% |
| 2023 | -0.25x | ₩-12.13 Billion | ₩48.36 Billion | ▲ +81.2% |
| 2022 | -1.34x | ₩-6.08 Billion | ₩4.54 Billion | ▼ -279.5% |
| 2021 | 0.74x | ₩10.91 Billion | ₩14.65 Billion | ▲ +22.0% |
| 2020 | 0.61x | ₩7.42 Billion | ₩12.15 Billion | ▼ -31.2% |
| 2019 | 0.89x | ₩6.43 Billion | ₩7.25 Billion | ▲ +20.1% |
| 2018 | 0.74x | ₩3.85 Billion | ₩5.21 Billion | ▼ -27.4% |
| 2017 | 1.02x | ₩3.82 Billion | ₩3.75 Billion | ▲ +1187.4% |
| 2016 | -0.09x | ₩-185.35 Million | ₩1.98 Billion | ▲ +91.5% |
| 2015 | -1.10x | ₩-1.33 Billion | ₩1.20 Billion | — |